4-diphenylacetoxy-1,1-dimethylpiperidinium has been researched along with Prediabetes in 1 studies
4-diphenylacetoxy-1,1-dimethylpiperidinium: muscarinic receptor antagonist; RN given refers to parent cpd; do not confuse abbreviation 4-DAMP with a similar cpd which does not contain dimethyl groups
4-DAMP(1+) : A quaternary ammonium salt obtained by formal methylation of the tertiary amino function of 4-diphenylacetoxy-N-methylpiperidine.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Clark, PB | 1 |
| Plaza, MJ | 1 |
| Kraas, J | 1 |
| Burbank, N | 1 |
| Elster, AW | 1 |
| Garg, P | 1 |
| Garg, S | 1 |
| Gage, HD | 1 |
| Calles-Escandon, J | 1 |
| Wagner, JD | 1 |
| Morton, K | 1 |
1 other study available for 4-diphenylacetoxy-1,1-dimethylpiperidinium and Prediabetes
| Article | Year |
|---|---|
Dual radiotracer analysis of cholinergic neuronal changes in prediabetic mouse pancreas.
Topics: Animals; Fluorine Radioisotopes; Fluorobenzenes; Insulin-Secreting Cells; Mice; Pancreas; Parasympat | 2009 |